Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature (original) (raw)

Abstract

Background

Nephrolithiasis is a frequent condition. While it is generally accepted that such condition carries a risk of recurrence over time, the exact risk and its predictors have been rarely quantitated. We aimed to estimate recurrence of kidney stones, overall and in specific subgroups, from randomized controlled trials (RCTs) of calcium stone formers.

Methods

Systematic review of RCTs of adult patients with idiopathic calcium kidney stones. Recurrence rates analyzed in subgroups based on type of intervention and other characteristics, using Poisson regression models.

Results

The analysis included 21 RCTs with 2168 participants over a median follow-up of 3.2 years (range 0.5–9.7). The median recurrence of kidney stones was 15 per 100 person–years (range 0–110). Recurrence was higher in those with two or more previous stone episodes compared to those with a single episode at enrolment (16 vs. 6 per 100 person–years, p < 0.001) and in those untreated or treated with dietary changes compared to those treated with drugs (26 vs. 23 vs. 9 per 100 person–years, p < 0.001). The effect of drugs on recurrence seemed to be beneficial only among those with two or more previous stone episodes.

Conclusions

The overall recurrence rate of stones depends on factors such as previous stone history and type of treatment. Dietary approaches seem to be more effective among single stone formers, whereas drugs seem to be more effective among recurrent stone formers.

Access this article

Log in via an institution

Subscribe and save

• Get 10 units per month
• Download Article/Chapter or eBook
• 1 Unit = 1 Article or 1 Chapter
• Cancel anytime Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

1. Scales CD, Smith AC, Hanley JM, Saigal CS (2012) Prevalence of kidney stones in the United States. Eur Urol 62:160–165
   Article PubMed PubMed Central Google Scholar
2. Fabris A, Lupo A, Fantin F et al (2011) Abnormal arterial stiffness and bone density in calcium renal stone formers. J Am Soc Nephrol JASN 22:388
   Google Scholar
3. Ferraro PM, Taylor EN, Eisner BH et al (2013) History of kidney stones and the risk of coronary heart disease. JAMA J Am Med Assoc 310(4):408–415
   Article CAS Google Scholar
4. Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: urolithiasis. J Urol 173:848–857
   Article PubMed Google Scholar
5. Uribarri J, Oh MS, Carroll HJ (1989) The first kidney stone. Ann Intern Med 111(12):1006–1009
   Article CAS PubMed Google Scholar
6. Borghi L, Schianchi T, Meschi T et al (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346(2):77–84
   Article CAS PubMed Google Scholar
7. Schissel BL, Johnson BK (2011) Renal stones: evolving epidemiology and management. Pediatr Emerg Care 27(7):676–681
   Article PubMed Google Scholar
8. Briggs A, Claxton K, Sculpher M (2006) Decision modelling for health economic evaluation, 1st edn. OUP, Oxford
   Google Scholar
9. Fink HA, Wilt TJ, Eidman KE et al (2013) Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med 158(7):535–543
   Article PubMed Google Scholar
10. Worcester EM, Coe FL (2010) Clinical practice. Calcium kidney stones. N Engl J Med 363(10):954–963
    Article CAS PubMed PubMed Central Google Scholar
11. Gambaro G, Reis-Santos JM, Rao N (2004) Nephrolithiasis: why doesn’t our “learning” progress? Eur Urol 45(5):547–556 (discussion 556)
    Article PubMed Google Scholar
12. Gambaro G, Valente ML, Zanetti E et al (2006) Mild tubular damage induces calcium oxalate crystalluria in a model of subtle hyperoxaluria: evidence that a second hit is necessary for renal lithogenesis. J Am Soc Nephrol JASN 17(8):2213–2219
    Article CAS PubMed Google Scholar
13. Ettinger B (1976) Recurrent nephrolithiasis: natural history and effect of phosphate therapy. A double-blind controlled study. Am J Med 61(2):200–206
    Article CAS PubMed Google Scholar
14. Smith MJ (1977) Placebo versus allopurinol for renal calculi. J Urol 117(6):690–692
    CAS PubMed Google Scholar
15. Johansson G, Backman U, Danielson BG, Fellström B, Ljunghall S, Wikström B (1982) Effects of magnesium hydroxide in renal stone disease. J Am Coll Nutr 1(2):179–185
    Article CAS PubMed Google Scholar
16. Scholz D, Schwille PO, Sigel A (1982) Double-blind study with thiazide in recurrent calcium lithiasis. J Urol 128(5):903–907
    CAS PubMed Google Scholar
17. Laerum E, Larsen S (1984) Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand 215(4):383–389
    Article CAS PubMed Google Scholar
18. Ettinger B, Tang A, Citron JT, Livermore B, Williams T (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315(22):1386–1389
    Article CAS PubMed Google Scholar
19. Mortensen JT, Schultz A, Ostergaard AH (1986) Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones. Int Urol Nephrol 18(3):265–269
    Article CAS PubMed Google Scholar
20. Borghi L, Meschi T, Guerra A, Novarini A (1993) Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22(Suppl 6):S78–S86
    Article PubMed Google Scholar
21. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150(6):1761–1764
    CAS PubMed Google Scholar
22. Hofbauer J, Höbarth K, Szabo N, Marberger M (1994) Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis—a prospective randomized study. Br J Urol 73(4):362–365
    Article CAS PubMed Google Scholar
23. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155:839–843
    Article CAS PubMed Google Scholar
24. Hiatt RA, Ettinger B, Caan B, Quesenberry CP, Duncan D, Citron JT (1996) Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol 144(1):25–33
    Article CAS PubMed Google Scholar
25. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158(6):2069–2073
    Article CAS PubMed Google Scholar
26. Kocvara R, Plasgura P, Petrík A, Louzenský G, Bartonícková K, Dvorácek J (1999) A prospective study of nonmedical prophylaxis after a first kidney stone. BJU Int 84(4):393–398
    Article CAS PubMed Google Scholar
27. Di Silverio F, Ricciuti GP, D’Angelo AR, Fraioli A, Simeoni G (2000) Stone recurrence after lithotripsy in patients with recurrent idiopathic calcium urolithiasis: efficacy of treatment with fiuggi water. Eur Urol 37(2):145–148
    Article PubMed Google Scholar
28. Soygür T, Akbay A, Küpeli S (2002) Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol 16(3):149–152
    Article PubMed Google Scholar
29. Micali S, Sighinolfi MC, Celia A et al (2006) Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study. J Urol 176(3):1020–1022
    Article CAS PubMed Google Scholar
30. Sarica K, Inal Y, Erturhan S, Yağci F (2006) The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy. Urol Res 34(3):184–189
    Article CAS PubMed Google Scholar
31. Dussol B, Iovanna C, Rotily M et al (2008) A randomized trial of low-animal-protein or high-fiber diets for secondary prevention of calcium nephrolithiasis. Nephron Clin Pract 110(3):c185–c194
    Article CAS PubMed Google Scholar
32. Lojanapiwat B, Tanthanuch M, Pripathanont C et al (2011) Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy. Int Braz J Urol 37(5):611–616
    Article CAS PubMed Google Scholar

Download references

Author information

Authors and Affiliations

1. Division of Nephrology, Fondazione Policlinico A. Gemelli, Catholic University of the Sacred Heart, Via Moscati 31-33, 00168, Rome, Italy
   Pietro Manuel Ferraro & Giovanni Gambaro
2. Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
   Pietro Manuel Ferraro & Gary C. Curhan
3. Renal Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
   Gary C. Curhan
4. Division of Urology, Fondazione Policlinico A. Gemelli, Catholic University of the Sacred Heart, Rome, Italy
   Alessandro D’Addessi

Authors

1. Pietro Manuel Ferraro
   You can also search for this author inPubMed Google Scholar
2. Gary C. Curhan
   You can also search for this author inPubMed Google Scholar
3. Alessandro D’Addessi
   You can also search for this author inPubMed Google Scholar
4. Giovanni Gambaro
   You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toPietro Manuel Ferraro.

Ethics declarations

Conflict of interest

PMF received consultant fees from BioHealth Italia. GCC: Consultant for Allena Pharmaceuticals, AstraZeneca, Exponent; Royalties: UpToDate (author and Section Editor); Honorarium: American Society of Nephrology (Editor-in-Chief, Clinical Journal of the American Society of Nephrology). PMF, ADA and GG have nothing to disclose. For this type of study formal consent is not required.

Funding

None.

Ethical approval

Described results do not directly include studies with human beings or animals.

Informed consent

Informed consent was not required.

Appendix 1: Research strategy

Appendix 1: Research strategy

PubMed Medline:

1. 1. Urolithiasis[mesh]
2. 1. Urolithiasis[tiab]
3. 1. Nephrolithiasis[tiab]
4. 1. Kidney calculi[tiab]
5. 1. Renal calculi[tiab]
6. 1. Kidney stones[tiab]
7. 1. Renal stones[tiab]
8. 1. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7
9. 1. Hypercalciuria[mesh]
10. 1. Hypercalciuri*
11. 1. Calcium[tiab]
12. 1. 9 OR 10 OR 11
13. 1. 8 AND 12
14. 1. Randomized controlled trial[pub type]
15. 1. Controlled clinical trial[pub type]
16. 1. Clinical trial[pub type]
17. 1. Randomized controlled trial[tiab]
18. 1. Clinical trial[tiab]
19. 1. 14 OR 15 OR 16 OR 17 OR 18
20. 1. 13 AND 19
21. 1. Animals[mesh]
22. 1. Humans[mesh]
23. 1. 21 NOT 22
24. 1. 20 NOT 23
25. 1. English[language]
26. 1. 24 AND 25
27. 1. Adults[mesh]
28. 1. 26 AND 27

Cochrane library:

1. 1. Urolithiasis[mesh]
2. 1. Urolithiasis[ti, ab, kw]
3. 1. Nephrolithiasis[ti, ab, kw]
4. 1. Kidney stones[ti, ab, kw]
5. 1. Renal stones[ti, ab, kw]
6. 1. Kidney calculi[ti, ab, kw]
7. 1. Renal calculi[ti, ab, kw]
8. 1. Hypercalciuria[mesh]
9. 1. Hypercalciuria[ti, ab, kw]
10. 1. Calcium[ti, ab, kw]
11. 1. (or #1-#7)
12. 1. (or #8-#10)

#11 and #12

Rights and permissions

About this article

Cite this article

Ferraro, P.M., Curhan, G.C., D’Addessi, A. et al. Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature.J Nephrol 30, 227–233 (2017). https://doi.org/10.1007/s40620-016-0283-8

Download citation

• Received: 10 December 2015
• Accepted: 08 February 2016
• Published: 11 March 2016
• Issue Date: April 2017
• DOI: https://doi.org/10.1007/s40620-016-0283-8

Keywords